Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7608021

Concept As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
14,221,000,000 JPY
Ordinary profit (loss)
1,329,000,000 JPY
Net assets
45,313,000,000 JPY
Total assets
81,717,000,000 JPY
Basic earnings (loss) per share
38.72
Diluted earnings per share
Equity-to-asset ratio
0.555 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.